ArticleCureus2024
Triglycerides and Sodium: Unmasking Pseudohyponatremia in a Clinical Case.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sodium is one of the most important minerals in human blood. Sodium disorders, either in the form of hypernatremia or hyponatremia, have detrimental effects on the body; therefore, they warrant urgent attention. Hyponatremia occurs in various clinical scenarios; it can be further categorized as true hyponatremia and pseudohyponatremia. When blood gets high protein or fat contents, it factitiously lowers the sodium level, which is termed pseudohyponatremia. The management scheme for both true hyponatremia and pseudohyponatremia is different; hence, careful clinical co-relation is needed while dealing with such scenarios. We present a case of a 59-year-old gentleman referred by a general practitioner for severe hyponatremia. The patient demonstrated hyperglycemia on admission, hence started on variable rate insulin, and further investigations had been done to screen for metabolic syndrome. Routine investigations showed severe hypertriglyceridemia, leading to a diagnosis of pseudohyponatremia. The patient had been discharged with the dual anti-lipid-lowering and anti-hyperglycemic regimen. This case denotes the importance of understanding and differentiating pseudohyponatremia from true hyponatremia, which is essential to avoid mismanagement of sodium levels in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.